Tg Therapeutics (TGTX) Shares Outstanding (2010 - 2026)
Tg Therapeutics (TGTX) posted quarterly Shares Outstanding (Entity) of $160.0 million for Q1 2026, up 0.77% year-over-year from $158.7 million in Q1 2025, and up 0.7% quarter-over-quarter from $158.8 million in Q4 2025.
Tg Therapeutics (TGTX) Shares Outstanding (2010 - 2026) Analysis & Trends
Tg Therapeutics' Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $160.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.77% year-over-year to $160.0 million; the TTM figure through Mar 2026 stood at $160.0 million (up 0.77% YoY), while the FY2025 annual figure was $158.8 million, up 1.69% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $160.0 million, up from $158.8 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $160.0 million in Q1 2026, with the low at $144.6 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $154.6 million (2024), against an average of $153.0 million.
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) increased 4.19% in 2023, then grew 0.77% in 2026.
- Tg Therapeutics' Shares Outstanding (Entity) stood at $146.4 million in 2022, then advanced by 3.44% to $151.5 million in 2023, then rose by 3.13% to $156.2 million in 2024, then rose by 1.69% to $158.8 million in 2025, then rose by 0.7% to $160.0 million in 2026.
- Business Quant data shows TGTX's Shares Outstanding (Entity) at $160.0 million in Q1 2026, $158.8 million in Q4 2025, and $158.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 141.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 141.77 Mn |
| Mar 31, 2026 | 144.44 Mn |
| Dec 31, 2025 | 144.32 Mn |
| Sep 30, 2025 | 145.42 Mn |
| Jun 30, 2025 | 146.74 Mn |
| Mar 31, 2025 | 146.68 Mn |
| Dec 31, 2024 | 145.32 Mn |
| Sep 30, 2024 | 145.10 Mn |
| Jun 30, 2024 | 144.73 Mn |
| Mar 31, 2024 | 146.21 Mn |
| Dec 31, 2023 | 141.96 Mn |
| Sep 30, 2023 | 142.87 Mn |
| Jun 30, 2023 | 141.50 Mn |
| Mar 31, 2023 | 140.31 Mn |
| Dec 31, 2022 | 135.41 Mn |
| Sep 30, 2022 | 135.33 Mn |
| Jun 30, 2022 | 134.78 Mn |
| Mar 31, 2022 | 134.40 Mn |
| Dec 31, 2021 | 132.22 Mn |
| Sep 30, 2021 | 132.35 Mn |